Heparin in sepsis: current clinical findings and possible mechanisms
Sepsis is a clinical syndrome resulting from the interaction between coagulation, inflammation, immunity and other systems. Coagulation activation is an initial factor for sepsis to develop into multiple organ dysfunction. Therefore, anticoagulant therapy may be beneficial for sepsis patients. Hepar...
Saved in:
Main Authors: | Sihan Yu, Yawen Chi, Xiaochun Ma, Xu Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1495260/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prescriber perceptions of the safety and efficacy of unfractionated heparin versus low molecular weight heparin in the acute treatment phase: a qualitative study
by: Danielle Green, et al.
Published: (2024-12-01) -
Unfractionated Heparin Enhances Sepsis Prognosis Through Inhibiting Drp1‐Mediated Mitochondrial Quality Imbalance
by: Ruixue Liu, et al.
Published: (2024-12-01) -
International normalized ratio measurement during perioperative anticoagulation bridging with low-molecular-weight heparin in patients undergoing heart valve replacement surgery
by: Liza Rijvers, et al.
Published: (2024-11-01) -
ASSOCIATION BETWEEN HEPARIN DOSE AND 6-WEEKS MORTALITY IN PATIENTS WITH COVID-19
by: Claire Coutureau, et al.
Published: (2022-04-01) -
Safety and efficacy of low-molecular-weight heparin in patients with acute venous thromboembolism postthrombolytic therapy as compared to unfractionated heparin: A systematic review and meta-analysis
by: Eman M. Mansory, et al.
Published: (2024-12-01)